OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Structure–Activity Relationship, Biological, and Pharmacological Characterization of the Proline Sulfonamide ACT‐462206: a Potent, Brain‐Penetrant Dual Orexin 1/Orexin 2 Receptor Antagonist
Christoph Boss, Catherine Roch‐Brisbare, Michel A. Steiner, et al.
ChemMedChem (2014) Vol. 9, Iss. 11, pp. 2486-2496
Closed Access | Times Cited: 38
Christoph Boss, Catherine Roch‐Brisbare, Michel A. Steiner, et al.
ChemMedChem (2014) Vol. 9, Iss. 11, pp. 2486-2496
Closed Access | Times Cited: 38
Showing 26-50 of 38 citing articles:
Oxadiazole Derivatives as Dual Orexin Receptor Antagonists: Synthesis, Structure–Activity Relationships, and Sleep‐Promoting Properties in Rats
Christine Brotschi, Catherine Roch, John Gatfield, et al.
ChemMedChem (2019) Vol. 14, Iss. 13, pp. 1257-1270
Closed Access | Times Cited: 10
Christine Brotschi, Catherine Roch, John Gatfield, et al.
ChemMedChem (2019) Vol. 14, Iss. 13, pp. 1257-1270
Closed Access | Times Cited: 10
Hypothalamic kinin B1 receptor mediates orexin system hyperactivity in neurogenic hypertension
Rohan Umesh Parekh, Acacia White, Korin E. Leffler, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 8
Rohan Umesh Parekh, Acacia White, Korin E. Leffler, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 8
From Oxadiazole to Triazole Analogues: Optimization toward a Dual Orexin Receptor Antagonist with Improved in vivo Efficacy in Dogs
Christine Brotschi, Martin H. Bolli, John Gatfield, et al.
ChemMedChem (2020) Vol. 15, Iss. 5, pp. 430-448
Closed Access | Times Cited: 6
Christine Brotschi, Martin H. Bolli, John Gatfield, et al.
ChemMedChem (2020) Vol. 15, Iss. 5, pp. 430-448
Closed Access | Times Cited: 6
Orexin receptors in GtoPdb v.2021.3
Paul J. Coleman, Luı́s de Lecea, Anthony L. Gotter, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2021) Vol. 2021, Iss. 3
Open Access | Times Cited: 4
Paul J. Coleman, Luı́s de Lecea, Anthony L. Gotter, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2021) Vol. 2021, Iss. 3
Open Access | Times Cited: 4
A comprehensive review of Dual Orexin Receptor Antagonist (DORA), Daridorexant: Novel drug for sleep and related disorders
Saurav Misra, Manmeet Kaur, Jayant Kumar Kairi
International journal of life sciences, biotechnology and pharma research. (2024) Vol. 13, Iss. 6, pp. 20-29
Open Access
Saurav Misra, Manmeet Kaur, Jayant Kumar Kairi
International journal of life sciences, biotechnology and pharma research. (2024) Vol. 13, Iss. 6, pp. 20-29
Open Access
Orexin receptors in GtoPdb v.2023.1
Gary Aston‐Jones, Pascal Bonaventure, Paul J. Coleman, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 1
Gary Aston‐Jones, Pascal Bonaventure, Paul J. Coleman, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 1
Substituted cyclopentanes, tetrahydrofurans and pyrrolidines as orexin-1-receptor antagonists for treatment of various CNS disorders (WO2015/055994; WO2015/124932; WO2015/124934)
Christoph Boss, Catherine Roch
Expert Opinion on Therapeutic Patents (2015) Vol. 26, Iss. 3, pp. 409-415
Closed Access | Times Cited: 1
Christoph Boss, Catherine Roch
Expert Opinion on Therapeutic Patents (2015) Vol. 26, Iss. 3, pp. 409-415
Closed Access | Times Cited: 1
Orexin Receptor Antagonists
Brock T. Shireman, Michael A. Letavic
Elsevier eBooks (2016), pp. 225-279
Closed Access | Times Cited: 1
Brock T. Shireman, Michael A. Letavic
Elsevier eBooks (2016), pp. 225-279
Closed Access | Times Cited: 1
The role of pharmacological interventions for sleep deprivation and restriction
Sara E. Alger, Emily Stekl, Sidney Allotey-Addo, et al.
Elsevier eBooks (2021), pp. 506-517
Closed Access | Times Cited: 2
Sara E. Alger, Emily Stekl, Sidney Allotey-Addo, et al.
Elsevier eBooks (2021), pp. 506-517
Closed Access | Times Cited: 2
Orexin Receptor Antagonists
Daniël Hoyer, Laura H. Jacobson
Current Sleep Medicine Reports (2017) Vol. 3, Iss. 4, pp. 342-353
Open Access | Times Cited: 1
Daniël Hoyer, Laura H. Jacobson
Current Sleep Medicine Reports (2017) Vol. 3, Iss. 4, pp. 342-353
Open Access | Times Cited: 1
Orexin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Paul J. Coleman, Luı́s de Lecea, Anthony L. Gotter, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2019) Vol. 2019, Iss. 4
Open Access | Times Cited: 1
Paul J. Coleman, Luı́s de Lecea, Anthony L. Gotter, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2019) Vol. 2019, Iss. 4
Open Access | Times Cited: 1
GRU-based de novo molecular generation and combinatorial virtual screening of OX1R antagonists
Xiaoqi Liang, Mei Hu, Minyao Qiu, et al.
Chemometrics and Intelligent Laboratory Systems (2022) Vol. 229, pp. 104638-104638
Closed Access | Times Cited: 1
Xiaoqi Liang, Mei Hu, Minyao Qiu, et al.
Chemometrics and Intelligent Laboratory Systems (2022) Vol. 229, pp. 104638-104638
Closed Access | Times Cited: 1
Suvorexant (Belsomra), The First‐in‐Class Orexin Antagonist for Insomnia
Nadia Ahmad
(2015), pp. 223-242
Closed Access
Nadia Ahmad
(2015), pp. 223-242
Closed Access
